RBC’s Top Digital Health Stocks For Continued Momentum This Year
With the pandemic forcing patients/providers to alter the way they sought/delivered health care, the digital health industry gained momentum last year. In a recent report,…
On the Radar Reports
This Biotech’s Unique Approach To Drug Development Could Give It The Best Chance Of Beating The Market This Year
When it comes to the author of today’s article’s top biotech stock pick for 2021, an under-the-radar name, he explains that “Many of the reasons…
Picks And Tips For Investing In “High-Risk But High-Potential” Blockchain Technology
Investing in bitcoin has become a hot topic over the last few years, as has investing in the technology behind bitcoin and other cryptocurrencies: blockchain.…
With Coronavirus Vaccines Still In Development, These 3 Stocks Are Poised To Soar This Year (With Some Risk)
In 2021, “The big stories…could come from vaccines that haven’t made it to market yet. It’s possible that the stocks of the companies developing these…
5 Health Care Stocks That Could Be Top Performers In 2021
Today’s article highlights five health care stocks that analysts believe could be top performers in 2021, with the author advising that “While certainly not as…
2020: The Year “The Dumb Money Was The Smart Money”
“The dumb money was the smart money this year,” is how one portfolio manager cited in today’s article sums up the wild swings experienced by…
3 Biotech Stocks With Enormous Catalysts Early In 2021
When it comes to stocks with the potential to make big moves in the first quarter of 2021, the author of today’s article advises that…
Top Biotech Picks For 2021 With The Most Upside Potential
In a new research report, Stifel identifies its 2021 picks from the biotech sector – and today’s article highlights the five Buy-rated stocks from that…
4 Under-$10 Biotech Stocks With Solid Upside Potential For Aggressive Traders
“Many investors, especially more aggressive traders, look at lower-priced stocks as a way to not only make some good money but to get a higher…
With A Focus On Genomics, This Lesser-Known ETF Is Outperforming – And Now May Be The Time To Buy
The lesser-known ETF discussed in today’s article is already beating the market – up 185% year to date – and the author believes it will…